Biological activity of selenium: Revisited

IUBMB Life

Volumn 68, Issue 2, 2016, Pages 97-105

  Wrobel, Jagoda K ^a   Power, Ronan ^b   Toborek, Michal ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b ALLTECH INC   (United States)

^c INSTITUTE OF SPORT SCIENCES   (Poland)

Author keywords

brain; cancer; human nutrition; selenium; selenoproteins

Indexed keywords

ENZYME; METHIONINE; METHIONINE SULFOXIDE REDUCTASE; SELENIUM; SELENIUM BINDING PROTEIN; SELENOMETHIONINE; SELENOPROTEIN; SELENOPROTEIN P; TYPE I IODOTHYRONINE DEIODINASE; UNCLASSIFIED DRUG; ANTIOXIDANT; SELENIUM DERIVATIVE; SELENOCYSTEINE; TRACE ELEMENT;

ANTIOXIDANT ACTIVITY; BIOLOGICAL ACTIVITY; CANCER MORTALITY; CANCER PREVENTION; CARDIOGENIC SHOCK; COGNITIVE DEFECT; CONGENITAL HYPOTHYROIDISM; CONGESTIVE HEART FAILURE; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG BRAIN LEVEL; DRUG METABOLISM; FERTILITY; HASHIMOTO DISEASE; HEART DISEASE; HUMAN; KASHIN BECK DISEASE; KESHAN DISEASE; LOW BIRTH WEIGHT; MUSCLE DISEASE; NEUROLOGIC DISEASE; NON MELANOMA SKIN CANCER; NONHUMAN; PREGNANCY; PROSTATE CANCER; REVIEW; SELENIUM DEFICIENCY; SINGLE NUCLEOTIDE POLYMORPHISM; METABOLISM;

ANTIOXIDANTS; HUMANS; MICRONUTRIENTS; SELENIUM; SELENIUM COMPOUNDS; SELENOCYSTEINE; SELENOPROTEINS;

EID: 84956581740     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1466     Document Type: Review

References (78)

1. Weekley, C. M., and, Harris, H. H., (2013) Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem. Soc. Rev. 42, 8870-8894.
2. Schwarz, K., Stesney, J. A., and, Foltz, C. M., (1959) Relation between selenium traces in L-cystine and protection against dietary liver necrosis. Metabolism 8, 88-90.
3. Fairweather-Tait, S. J., Bao, Y., Broadley, M. R., Collings, R., Ford, D., et al., (2011) Selenium in human health and disease. Antioxid. Redox Signal. 14, 1337-1383.
4. Labunskyy, V. M., Hatfield, D. L., and, Gladyshev, V. N., (2014) Selenoproteins: molecular pathways and physiological roles. Physiol. Rev. 94, 739-777.
5. El-Bayoumy, K., (2001) The protective role of selenium on genetic damage and on cancer. Mutat. Res. 475, 123-139.
6. Hatfield, D. L., Tsuji, P. A., Carlson, B. A., and, Gladyshev, V. N., (2014) Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem. Sci. 39, 112-120.
7. Labunskyy, V. M., Lee, B. C., Handy, D. E., Loscalzo, J., Hatfield, D. L., et al., (2011) Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice. Antioxid. Redox Signal. 14, 2327-2336.
8. Rayman, M. P., (2012) Selenium and human health. Lancet 379, 1256-1268.
9. Shanu, A., Groebler, L., Kim, H. B., Wood, S., Weekley, C. M., et al., (2013) Selenium inhibits renal oxidation and inflammation but not acute kidney injury in an animal model of rhabdomyolysis. Antioxid. Redox Signal. 18, 756-769.
10. Seale, L. A., Gilman, C. L., Hashimoto, A. C., Ogawa-Wong, A. N., and, Berry, M. J., (2015) Diet-induced obesity in the selenocysteine lyase knockout mouse. Antioxid. Redox Signal. 23, 761-774.
11. Toulis, K. A., Anastasilakis, A. D., Tzellos, T. G., Goulis, D. G., and, Kouvelas, D., (2010) Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid 20, 1163-1173.
12. Pieczynska, J., and, Grajeta, H., (2015) The role of selenium in human conception and pregnancy. J. Trace Elem. Med. Biol. 29, 31-38.
13. Lescure, A., Rederstorff, M., Krol, A., Guicheney, P., and, Allamand., V., (2009) Selenoprotein function and muscle disease. Biochim. Biophys. Acta 1790, 1569-1574.
14. Chen, J., and, Berry, M. J., (2003) Selenium and selenoproteins in the brain and brain diseases. J. Neurochem. 86, 1-12.
15. Brooks, J. D., Metter, E. J., Chan, D. W., Sokoll, L. J., Landis, P., et al., (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. J. Urol. 166, 2034-2038.
16. Flores-Mateo, G., Navas-Acien, A., Pastor-Barriuso, R., and, Guallar, E., (2006) Selenium and coronary heart disease: a meta-analysis. Am. J. Clin. Nutr. 84, 762-773.
17. Amaral, A. F., Cantor, K. P., Silverman, D. T., and, Malats, N., (2010) Selenium and bladder cancer risk: a meta-analysis. Cancer. Epidemiol. Biomarkers Prev. 19, 2407-2415.
18. Hughes, D. J., Fedirko, V., Jenab, M., Schomburg, L., Meplan, C., et al., (2015) Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort. Int. J. Cancer 136, 1149-1161.
19. Burbano, X., Miguez-Burbano, M. J., McCollister, K., Zhang, G., Rodriguez, A., et al., (2002) Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants. HIV Clin. Trials 3, 483-491.
20. Letavayova, L., Vlckova, V., and, Brozmanova, J., (2006) Selenium: from cancer prevention to DNA damage. Toxicology 227, 1-14.
21. Kurokawa, S., and, Berry, M. J., (2013) Selenium. Role of the essential metalloid in health. Met. Ions Life Sci. 13, 499-534.
22. Thomson, C. D., (2004) Assessment of requirements for selenium and adequacy of selenium status: a review. Eur. J. Clin. Nutr. 58, 391-402.
23. Schrauzer, G. N., (2001) Nutritional selenium supplements: product types, quality, and safety. J. Am. Coll. Nutr. 20, 1-4.
24. Patrick, L., (2004) Selenium biochemistry and cancer: a review of the literature. Altern. Med. Rev. 9, 239-258.
25. Jackson, M. I., and, Combs, G. F. J., (2008) Selenium and anticarcinogenesis: underlying mechanisms. Curr. Opin. Clin. Nutr. Metab. Care 11, 718-726.
26. Chen, Y. C., Prabhu, K. S., and, Mastro, A. M., (2013) Is selenium a potential treatment for cancer metastasis? Nutrients 5, 1149-1168.
27. Meplan, C., (2015) Selenium and chronic diseases: a nutritional genomics perspective. Nutrients 7, 3621-3651.
28. Kasaikina, M. V., Hatfield, D. L., and, Gladyshev, V. N., (2012) Understanding selenoprotein function and regulation through the use of rodent models. Biochim. Biophys. Acta 1823, 1633-1642.
29. Fernandes, A. P., and, Gandin, V., (2015) Selenium compounds as therapeutic agents in cancer. Biochim. Biophys. Acta 1850, 1642-1660.
30. Schomburg, L., and, Schweizer, U., (2009) Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochim. Biophys. Acta 1790, 1453-1462.
31. Davis, C. D., Tsuji, P. A., and, Milner, J. A., (2012) Selenoproteins and cancer prevention. Annu. Rev. Nutr. 32, 73-95.
32. Combs, G. F. J., (2015) Biomarkers of selenium status. Nutrients 7, 2209-2236.
33. Lee, B. C., Dikiy, A., Kim, H. Y., and, Gladyshev, V. N., (2009) Functions and evolution of selenoprotein methionine sulfoxide reductases. Biochim. Biophys. Acta 1790, 1471-1477.
34. Achilli, C., Ciana, A., and, Minetti, G., (2015) The discovery of methionine sulfoxide reductase enzymes: an historical account and future perspectives. BioFactors 41, 135-152.
35. Kim, H. Y., (2013) The methionine sulfoxide reduction system: selenium utilization and methionine sulfoxide reductase enzymes and their functions. Antioxid. Redox Signal. 19, 958-969.
36. Kaya, A., Lee, B. C., and, Gladyshev, V. N., (2015) Regulation of protein function by reversible methionine oxidation and the role of selenoprotein MsrB1. Antioxid. Redox Signal. 23, 814-822.
37. Lee, B. C., Peterfi, Z., Hoffmann, F. W., Moore, R. E., Kaya, A., et al., (2013) MsrB1 and MICALs regulate actin assembly and macrophage function via reversible stereoselective methionine oxidation. Mol. Cell 51, 397-404.
38. Bar-Noy, S., and, Moskovitz, J., (2002) Mouse methionine sulfoxide reductase B: effect of selenocysteine incorporation on its activity and expression of the seleno-containing enzyme in bacterial and mammalian cells. Biochem. Biophys. Res. Commun. 297, 956-961.
39. Schrauzer, G. N., (2000) Selenomethionine: a review of its nutritional significance, metabolism and toxicity. J. Nutr. 130, 1653-1656.
40. Finley, J. W., (2006) Bioavailability of selenium from foods. Nutr. Rev. 64, 146-151.
41. Martinez, J., Lisa, S., Sanchez, R., Kowalczyk, W., Zurita, E., et al., (2011) Selenomethionine incorporation into amyloid sequences regulates fibrillogenesis and toxicity. PloS One 6, e27999
42. Zhang, S., Rocourt, C., and, Cheng, W. H., (2010) Selenoproteins and the aging brain. Mech. Ageing Dev. 131, 253-260.
43. Ansong, E., Yang, W., and, Diamond, A. M., (2014) Molecular cross-talk between members of distinct families of selenium containing proteins. Mol. Nutr. Food Res. 58, 117-123.
44. Zhang, J., Dong, W. G., and, Lin, J., (2011) Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma. Med. Oncol. 28, 481-487.
45. Ha, Y. S., Lee, G. T., Kim, Y. H., Kwon, S. Y., Choi, S. H., et al., (2014) Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma. World J. Surg. Oncol. 12, 288
46. Wallenberg, M., Misra, S., and, Bjornstedt, M., (2014) Selenium cytotoxicity in cancer. Basic Clin. Pharmacol. Toxicol. 114, 377-386.
47. Roman, M., Jitaru, P., and, Barbante, C., (2014) Selenium biochemistry and its role for human health. Metallomics 6, 25-54.
48. Nickel, A., Kottra, G., Schmidt, G., Danier, J., Hofmann, T., et al., (2009) Characteristics of transport of selenoamino acids by epithelial amino acid transporters. Chem. Biol. Interact. 177, 234-241.
49. Jung, H. J., and, Seo, Y. R., (2010) Current issues of selenium in cancer chemoprevention. BioFactors 36, 153-158.
50. Song, H., Hur, I., Park, H. J., Nam, J., Park, G. B., et al., (2009) Selenium inhibits metastasis of murine melanoma cells through the induction of cell cycle arrest and cell death. Immune Netw. 9, 236-242.
51. Chen, Y. C., Prabhu, K. S., Das, A., and, Mastro, A. M., (2013) Dietary selenium supplementation modifies breast tumor growth and metastasis. Int. J. Cancer 133, 2054-2064.
52. Tan, Q., Li, J., Yin, H. W., Wang, L. H., Tang, W. C., et al., (2010) Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo. Invest. New Drugs 28, 205-215.
53. Puspitasari, I. M., Abdulah, R., Yamazaki, C., Kameo, S., Nakano, T., et al., (2014) Updates on clinical studies of selenium supplementation in radiotherapy. Radiat. Oncol. 9, 125
54. Yakubov, E., Buchfelder, M., Eyupoglu, I. Y., and, Savaskan, N. E., (2014) Selenium action in neuro-oncology. Biol. Trace Elem. Res. 161, 246-254.
55. Clark, L. C., Combs, G. F. J., Turnbull, B. W., Slate, E. H., Chalker, D. K., et al., (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957-1963.
56. Lippman, S. M., Klein, E. A., Goodman, P. J., Lucia, M. S., Thompson, I. M., et al., (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39-51.
57. Meplan, C., Hughes, D. J., Pardini, B., Naccarati, A., Soucek, P., et al., (2010) Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis 31, 1074-1079.
58. Mathers, J. C., and, Hesketh, J. E., (2007) The biological revolution: understanding the impact of SNPs on diet-cancer interrelationships. J. Nutr. 137, 253S-258S.
59. Hu, Y. J., Korotkov, K. V., Mehta, R., Hatfield, D. L., Rotimi, C. N., et al., (2001) Distribution and functional consequences of nucleotide polymorphisms in the 3′-untranslated region of the human Sep15 gene. Cancer Res 61, 2307-2310.
60. Villette, S., Kyle, J. A., Brown, K. M., Pickard, K., Milne, J. S., et al., (2002) A novel single nucleotide polymorphism in the 3′ untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol. Dis. 29, 174-178.
61. Sanmartin, C., Plano, D., Font, M., and, Palop, J. A., (2011) Selenium and clinical trials: new therapeutic evidence for multiple diseases. Curr. Med. Chem. 18, 4635-4650.
62. Brozmanova, J., Manikova, D., Vlckova, V., and, Chovanec, M., (2010) Selenium: a double-edged sword for defense and offence in cancer. Arch. Toxicol. 84, 919-938.
63. Zhan, X., Qie, Y., Wang, M., Li, X., and, Zhao, R., (2011) Selenomethionine: an effective selenium source for sow to improve Se distribution, antioxidant status, and growth performance of pig offspring. Biol. Trace Elem. Res. 142, 481-491.
64. Kouba, A., Velisek, J., Stara, A., Masojidek, J., and, Kozak, P., (2014) Supplementation with sodium selenite and selenium-enriched microalgae biomass show varying effects on blood enzymes activities, antioxidant response, and accumulation in common barbel (Barbus barbus). Biomed Res. Int. 2014, 408270
65. Whanger, P. D., (2004) Selenium and its relationship to cancer: an update. Brit. J. Nutr. 91, 11-28.
66. Umysova, D., Vitova, M., Douskova, I., Bisova, K., Hlavova, M., et al., (2009) Bioaccumulation and toxicity of selenium compounds in the green alga Scenedesmus quadricauda. BMC Plant Biol. 9, 58
67. Sun, X., Zhong, Y., Huang, Z., and, Yang, Y., (2014) Selenium accumulation in unicellular green alga Chlorella vulgaris and its effects on antioxidant enzymes and content of photosynthetic pigments. PloS One 9, e112270
68. Selenius, M., Rundlof, A. K., Olm, E., Fernandes, A. P., and, Bjornstedt, M., (2010) Selenium and the selenoprotein thioredoxin reductase in the prevention, treatment and diagnostics of cancer. Antioxid. Redox Signal. 12, 867-880.
69. Nakayama, A., Hill, K. E., Austin, L. M., Motley, A. K., and, Burk, R. F., (2007) All regions of mouse brain are dependent on selenoprotein P for maintenance of selenium. J. Nutr. 137, 690-693.
70. Burk, R. F., and, Hill, K. E., (2009) Selenoprotein P-expression, functions, and roles in mammals. Biochim. Biophys. Acta 1790, 1441-1447.
71. Trapp, G. A., and, Millam, J., (1975) The distribution of 75Se in brains of selenium-deficient rats. J. Neurochem. 24, 593-595.
72. Hill, K. E., Zhou, J., McMahan, W. J., Motley, A. K., Atkins, J. F., et al., (2003) Deletion of selenoprotein P alters distribution of selenium in the mouse. J. Biol Chem 278, 13640-13646.
73. Schomburg, L., Schweizer, U., Holtmann, B., Flohe, L., Sendtner, M., et al., (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem. J. 370, 397-402.
74. Burk, R. F., Hill, K. E., Olson, G. E., Weeber, E. J., Motley, A. K., et al., (2007) Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed. J. Neurosci. 27, 6207-6211.
75. Scharpf, M., Schweizer, U., Arzberger, T., Roggendorf, W., Schomburg, L., et al., (2007) Neuronal and ependymal expression of selenoprotein P in the human brain. J. Neural. Transm. 114, 877-884.
76. Olson, G. E., Winfrey, V. P., Nagdas, S. K., Hill, K. E., and, Burk, R. F., (2007) Apolipoprotein E receptor-2 (ApoER2) mediates selenium uptake from selenoprotein P by the mouse testis. J. Biol. Chem. 282, 12290-12297.
77. Burk, R. F., Hill, K. E., Motley, A. K., Winfrey, V. P., Kurokawa, S., et al., (2014) Selenoprotein P and apolipoprotein E receptor-2 interact at the blood-brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration. Faseb J. 28, 3579-3588.
78. Yang, X., Hill, K. E., Maguire, M. J., and, Burk, R. F., (2000) Synthesis and secretion of selenoprotein P by cultured rat astrocytes. Biochim. Biophys. Acta 1474, 390-396.